Varsha V Moudgal
Overview
Explore the profile of Varsha V Moudgal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
119
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Duggan J, Sahloff E, Moudgal V
Pharmacotherapy
. 2005 May;
25(5):698-708.
PMID: 15899732
Antiretroviral agents, especially nucleoside reverse transcriptase inhibitors, require significant dosage adjustments in patients who have renal dysfunction and the human immunodeficiency virus (HIV). Some antiretroviral agents and fixed combination preparations...
2.
Moudgal V, Sobel J
Curr Opin Investig Drugs
. 2004 Dec;
5(8):873-8.
PMID: 15600244
The use of antifungal agents in patients with renal insufficiency requires careful consideration of not only the degree of renal insufficiency, but also other factors such as the fungal organism...
3.
Kaatz G, Moudgal V, Seo S, Hansen J, Kristiansen J
Int J Antimicrob Agents
. 2003 Sep;
22(3):254-61.
PMID: 13678830
Structural variants of phenylpiperidine selective serotonin reuptake inhibitors (P-SSRIs) inhibited the function of two unique Staphylococcus aureus multidrug efflux pumps. The most active compound was the paroxetine isomer NNC 20-7052,...
4.
Moudgal V, Sobel J
Expert Opin Drug Saf
. 2003 Aug;
2(5):475-83.
PMID: 12946248
The use of any medication in pregnant women requires careful consideration of benefit to the mother versus risk posed to the fetus. Fungal infections are not uncommon in pregnant women;...
5.
Kaatz G, Moudgal V, Seo S, Kristiansen J
Antimicrob Agents Chemother
. 2003 Jan;
47(2):719-26.
PMID: 12543683
Efflux-related multidrug resistance (MDR) is a significant means by which bacteria can evade the effects of selected antimicrobial agents. Genome sequencing data suggest that Staphylococcus aureus may possess numerous chromosomally...
6.
Kaatz G, Moudgal V, Seo S
J Antimicrob Chemother
. 2002 Dec;
50(6):833-8.
PMID: 12461001
Moxifloxacin is a C8-methoxy (C8-OMe) fluoroquinolone that is highly active against Staphylococcus aureus, including many strains resistant to older fluoroquinolones such as ciprofloxacin. Available data indicate that it is a...